Acorah Software Products - Accounts Production 19.3.600 false true false true No description of principal activity 1 December 2024 30 November 2025 30 November 2025 16067914 D Sharma iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16067914 2024-11-30 16067914 2025-11-30 16067914 2024-12-01 2025-11-30 16067914 frs-core:CurrentFinancialInstruments 2025-11-30 16067914 frs-bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 16067914 frs-bus:FilletedAccounts 2024-12-01 2025-11-30 16067914 frs-bus:Micro-entities 2024-12-01 2025-11-30 16067914 frs-bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 16067914 frs-bus:Director1 2024-12-01 2025-11-30
Registered number: 16067914
Dev Sharma Medical Consultation Ltd
Unaudited Financial Statements
For The Year Ended 30 November 2025
Dev Sharma Medical Consultation Ltd
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 16067914

| 2025
--- | ---
|  | £
Current assets |  | 45,981
Creditors: Amounts Falling Due Within One Year |  | (35,543 )
NET CURRENT ASSETS |  | 10,438
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 10,438
NET ASSETS |  | 10,438
CAPITAL AND RESERVES |  | 10,438

## Notes

1. General Information
Dev Sharma Medical Consultation Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16067914 . The registered office is 149 Armley Ridge Road , Leeds, LS12 2QT.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

D Sharma Director
3rd August 2026